Press release
Surge in Biopharmaceutical Industry Drives Albumin Excipient Market: Expected to Reach $6.77 Billion by 2029 with a CAGR of 6.8%
_x000D_The albumin excipient market is expected to grow steadily, driven by rising chronic disease prevalence and advancements in clinical applications._x000D_
_x000D_
What Is The Projected Market Size Of The Global Albumin Excipient Market And Its Growth Rate?_x000D_
• Projected growth from $4.85 billion in 2024 to $5.2 billion in 2025 (CAGR of 7.1%)_x000D_
• Expected to reach $6.77 billion in 2029, growing at a CAGR of 6.8%_x000D_
This growth can be attributed to increased adoption of biologics and biodegradable properties, rising geriatric population, and increasing global vaccination initiatives, among other factors._x000D_
_x000D_
What Is Driving The Growth In The Albumin Excipient Market?_x000D_
The albumin excipient market's growth is largely driven by the rising prevalence of chronic diseases. Albumin is predominantly used in treating various illnesses, including cancer and diabetes, due to its multifaceted protein carrier properties and ability to improve the pharmacokinetic profiles of peptide or protein-based drugs. The World Health Organization projects that by 2050, over 35 million new cancer cases will emerge, marking a 77% increase compared to the estimated 20 million cases in 2022. This surge in chronic diseases is expected to propel the growth of the albumin excipient market._x000D_
_x000D_
Request A Free Sample Copy Here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp_x000D_
_x000D_
Who Are the Key Players Driving Albumin Excipient Market Growth?_x000D_
• Albumin Therapeutics LLC_x000D_
• Biotest AG_x000D_
• CSL Behring_x000D_
• Grifols S.A._x000D_
• HiMedia Laboratories LLC_x000D_
• InVitria Inc._x000D_
• Medxbio Pte Ltd._x000D_
• Octapharma AG_x000D_
• RayBiotech Inc._x000D_
• SeraCare Life Sciences Inc._x000D_
• Sigma-Aldrich Pty. Ltd._x000D_
• Hualan Biological Engineering Inc._x000D_
• Kedrion Biopharma_x000D_
• LFB USA Inc._x000D_
• Shanghai RAAS Blood Products Co. Ltd._x000D_
• Baxter International Inc._x000D_
• Merck KGaA_x000D_
• Thermo Fisher Scientific Inc._x000D_
• Albumedix A/S_x000D_
• Bio Products Laboratory Ltd._x000D_
• Shire Plc._x000D_
• Ventria Bioscience Inc._x000D_
• Novartis AG_x000D_
• China Biologic Products Holdings Inc._x000D_
• ProMetic Life Sciences Inc._x000D_
• Sanquin_x000D_
• Biopharma_x000D_
• Takeda Pharmaceutical Company Limited_x000D_
• FUJIFILM Irvine Scientific Inc._x000D_
_x000D_
What Are The Key Trends In The Albumin Excipient Market?_x000D_
• Biodegradable and Biocompatible Properties of Albumin_x000D_
• Collaborations and Partnerships in Research_x000D_
• Regulatory Compliance and Quality Standards_x000D_
• Application in Cell Therapy_x000D_
• Customization and Tailored Solutions_x000D_
_x000D_
What Are The Segments Of The Global Albumin Excipient Market?_x000D_
• By Product: Human Serum Albumin, Recombinant Albumin_x000D_
• By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users_x000D_
_x000D_
Which Region Leads The Albumin Excipient Market?_x000D_
North America was the largest region in the Albumin Excipient market in 2024, while Asia-Pacific is expected to be the fastest-growing region in the upcoming years._x000D_
_x000D_
Pre-book the report for swift delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report_x000D_
_x000D_
What Is Covered In The Albumin Excipient Market Global Market Report?_x000D_
- Market Size Analysis: Analyze the Albumin Excipient Market size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the Albumin Excipient Market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall Albumin Excipient Market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the Albumin Excipient Market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Request customization for this report: https://www.thebusinessresearchcompany.com/Customise?id=10672&type=smp_x000D_
_x000D_
Learn More About The Business Research Company_x000D_
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation offering comprehensive and data-rich research and insights. With 1,500,000 datasets, our in-depth secondary research and unique insights from industry leaders help you stay ahead. Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive forecasts to support informed decision-making._x000D_
_x000D_
Contact Us:_x000D_
The Business Research Company_x000D_
Europe: +44 207 1930 708_x000D_
Asia: +91 88972 63534_x000D_
Americas: +1 315 623 0293_x000D_
Email: info@tbrc.info_x000D_
_x000D_
Follow Us On:_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company _x000D_
Twitter: https://twitter.com/tbrc_info _x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surge in Biopharmaceutical Industry Drives Albumin Excipient Market: Expected to Reach $6.77 Billion by 2029 with a CAGR of 6.8% here
News-ID: 3829119 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Albumin
rHu Albumin Market Key Players Analysis - Merck KGaA, HiMedia Laboratories Pvt. …
"rHu Albumin Market" in terms of revenue was estimated to be worth $94.88 million in 2023 and is poised to reach $218.56 million by 2031, growing at a CAGR of 11.16% from 2024 to 2031 according to a new report by Insight Ace Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1482
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global rHu Albumins market are:
• Increase in…
Rhu Albumin Market Future Business Opportunities 2024-2031 | Albumin Bioscience, …
The Latest research report on the Rhu Albumin Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Rhu Albumin Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics,…
Rhu Albumin Market Growth in Future Scope 2024-2031 | HiMedia Laboratories Pvt. …
Rhu Albumin Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Rhu Albumin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Rhu Albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful…
rHu Albumin Market: A Catalyst for Innovation in Trauma Care, Albumin Replacemen …
"rHu Albumin Market" in terms of revenue was estimated to be worth $94.88 million in 2023 and is poised to reach $218.56 million by 2031, growing at a CAGR of 11.16% from 2024 to 2031 according to a new report by Insight Ace Analytic.
Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1482
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global rHu Albumins market are:
• Increase in prevalence of rare diseases,…
Exploring the Growing Demand for Albumin in the Global Albumin Market
Introduction:
Albumin is a protein that is primarily produced by the liver and is found in human blood plasma. It plays a crucial role in maintaining the osmotic pressure of blood and transporting various substances such as hormones, fatty acids, and drugs. Albumin is widely used in various medical applications such as blood volume expansion, treatment of burns, liver diseases, and hypovolemic shock. With the growing prevalence of chronic diseases such…
Albumin Market: Therapeutic Action of Albumin on Liver Function and Blood Circul …
The use of albumin to treat multiple types of deficiencies, including those related to blood volume, is giving an impetus to market growth. It is a high-utility, human-derived protein that has applications across a spectrum of medical operations. Conditions such as hypoalbuminemia, caused by severe injuries, and rapid protein loss due to third-degree burns can be effectively managed through intravenous administration of albumin. Furthermore, albumin administration is the last resort…
